In a new weekly video series, STAT's @HoganAlex examines the stakes of ongoing court battles over NIH grant funding.

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Researchers found after bariatric procedures, patients lost an average of 58 pounds after two years, compared to 12 pounds ...

Americans are sicker and shorter-lived than people in other rich countries. Here’s how to fix that. Health and Human Services ...

A listing for a hidden camera resembling the one in their room raised alarms for a family staying at a vacation rental.

Researchers at the University of Arizona have identified oats as a food that may have effects similar to those of a ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

Two companion papers out of Rutgers University — published June 14 in Nature Metabolism and Nature Communications—have traced ...

Whether you’re taking Ozempic for type 2 diabetes or for weight loss, you’re probably noticing a lot of changes in your body.

WEIGHT loss jabs have taken the UK by storm – but for those looking for a more natural alternative, there’s a food everyone’s talking about. It’s been dubbed ‘the ...

Semaglutide medications like Ozempic and Wegovy have shown proven results for managing conditions like type 2 diabetes and obesity. Also known as GLP-1 agonists, these drugs work by mimicking a ...